Table 1.
LncRNA with potential as a diagnostic marker in clinical samples
| Cancer type | lncRNA | lncRNA in clinical samples | Reference |
|---|---|---|---|
| Liver cancer | ZNF385D-AS2, D16366 | Low expression in HCC tissues | [66,67] |
| SNHG1, SNHG12, LINC00511, HCG18, FGD5-AS1, CERS6-AS1, NUTM2A-AS1, SNHG16, ASB16-AS1, SNHG11, MINCR | High expression in HCC tissues | [68-70] | |
| Lung cancer | JPX | High expression in metastatic lung cancer tissues | [71] |
| DANCR | High expression in terminal lung cancer tissues | [73] | |
| PSMA3-AS1, TUC338 | High expression in lung cancer tissue | [72,74] | |
| DLEU2, AC020978 | High expression in NSCLC tissues | [75,76] | |
| SFTA1P, LINC01272, GATA6-AS1, MIR3945HG, LINC01314 | High expression in LUSC tissues | [76] | |
| LINC01572 | Low expression in LUSC tissues | [77] | |
| Gastric cancer | PTCSC3 | Low plasma levels in patients | [78] |
| NEAT1, AK023391, MIR4435-2HG, MAGI2-AS3 | High expression in cancer tissues | [79-82] | |
| Colorectal cancer | SNHG16, CACS15, CYTOR, MALAT1, TUG1, NEAT1, MIR17HG, H19 | High expression in CRC tissues | [83-85] |
| MEG3 | Low expression in CRC tissues | [86] | |
| Breast cancer | FAM83H-AS1, lncRNA-ATB | High serum levels in breast cancer patients | [87] |
| LINC0092, C2orf71 | Low expression in breast cancer tissues | [88] | |
| 362 | High expression in ER-positive breast cancer tissues | [89] | |
| NFIA-AS1 | Low expression in ER-positive breast cancer tissues | [89] | |
| Bladder cancer | PCAT6, HOTAIR | High expression in cancer tissues | [90,91] |
| UCA1 | High levels in urine and serum of bladder cancer patients | [91] | |
| GAS5 | Low expression in cancer tissues | [91] | |
| Pancreatic cancer | UFC1 | High serum levels in patients | [92] |
| Cervical cancer | FALEC | High plasma levels in patients | [93] |
| Ovarian cancer | ACTA2-AS1, CARD8-AS1, HHIP-AS1, HOTAIRM1, LINC00605, LINC01503, LINC01547, MIR155HG, OTUD6B-AS1 | High probability in low expression patients | [94] |
| HCP5, ITGB2-AS1, LINC00324, MIR31HG, PSMG3-AS1, ZBED5-AS1, SH3PXD2A-AS1 | High probability in high expression patients | ||
| Osteosarc-oma | TP73-AS1 | High expression in osteosarcoma tissues | [95] |
| Laryngeal carcinoma | lncRNA-ATB | High expression in laryngeal carcinoma tissues | [96] |
| Brain tumor | HOTAIR | High serum levels in brain tumor patients | [97] |
LncRNA, long non-coding RNA; HCC, hepatocellular carcinoma; NSCLC, non-small cell lung cancer; LUSC, lung squamous cell carcinoma; CRC, colorectal cancer; ER, estrogen receptor.